Document Detail

Pro B-type natriuretic peptide plasma value: A new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
MedLine Citation:
PMID:  23280329     Owner:  NLM     Status:  Publisher    
BACKGROUND: To determine the prognostic value of pro B-type natriuretic peptide (pro-BNP) to predict mortality after transcatheter aortic valve implantation (TAVI). Logistic EuroSCORE (LES) overestimates observed mortality after TAVI. A new risk score specific to TAVI is needed to accurately assess mortality and outcome. METHODS: Eighty-five patients were included. Indications for TAVI were nonoperable or surgically high-risk patients (LES>20%). Pro-BNP was measured 24h before the procedure. Cox proportional hazards model was used to evaluate clinical factors. The predictive accuracy of these Cox models was determined by using time-dependent receiver operating characteristic (ROC) curves. RESULTS: Pro-BNP levels (log-transformed) were significantly higher in non-survivors than in survivors at 30days (3.36±0.43 vs. 3.81±0.43, p<0.004) and at the end of follow-up (3.34±0.42 vs. 3.63±0.48, p<0.011). Multivariate analysis revealed that only increased log pro-BNP levels were associated with higher mortality rate at short [hazard ratio (HR) (95% confidence intervals (CI)]=5.35 (1.74-16.5), p=0.003] and long-term follow-ups [HR=11 (CI: 1.51-81.3), p=0.018]. LES was not associated with increased mortality at either time point [HR=1.03 (CI: 0.95-1.10), p=0.483 and HR=1.03 (CI: 0.98-1.07), p=0.230, respectively]. At 30, 90, 180, and 365days, the c-index was 0.72 for log pro-BNP and 0.63 for LES (p=0.044). CONCLUSION: Pre-procedure log transform of plasma pro-BNP levels are an independent and strong predictor of short- and long-term outcomes after TAVI and are more discriminatory than LES.
Diego López-Otero; Ramiro Trillo-Nouche; Francisco Gude; Belen Cid-Álvarez; Raimundo Ocaranza-Sanchez; Melisa Santas Alvarez; Pamela V Lear; José R Gonzalez-Juanatey
Related Documents :
17459739 - Cinrg pilot trial of oxatomide in steroid-naïve duchenne muscular dystrophy.
16358229 - Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases ...
18154419 - Cyclosporine in the treatment of membranoproliferative glomerulonephritis.
17175369 - Effect of plasmapheresis for acute humoral rejection after heart transplantation.
23928319 - Autograft versus nonirradiated allograft tissue for anterior cruciate ligament reconstr...
17322439 - Unicameral bone cysts: a comparison of injection of steroid and grafting with autologou...
23790469 - Single- and multi-level anterior decompression and fusion for cervical spondylotic myel...
18317859 - A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years.
18279579 - Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly pa...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-29
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Clinical University Hospital of Santiago de Compostela, Spain. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Construction of an inducible cell-communication system that amplifies Salmonella gene expression in ...
Next Document:  CHADS(2) score and risk of new-onset atrial fibrillation: A nationwide cohort study in Taiwan.